Filing Details
- Accession Number:
- 0001055666-10-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-29 13:36:30
- Reporting Period:
- 2010-12-28
- Filing Date:
- 2010-12-29
- Accepted Time:
- 2010-12-29 13:36:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 716054 | Cypress Bioscience Inc | CYPB | Biological Products, (No Disgnostic Substances) (2836) | 222389839 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1055666 | D Jay Kranzler | 4350 Executive Drive Suite 214 San Diego CA 92121 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-12-28 | 25,000 | $3.25 | 121,742 | No | 4 | M | Indirect | By Trust |
| Common Stock | Disposition | 2010-12-28 | 25,000 | $6.46 | 96,742 | No | 4 | S | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2010-12-28 | 25,000 | $0.00 | 25,000 | $3.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 34,229 | 2012-04-29 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 625 | Direct |
Footnotes
- The weighted average sale price for the transaction reported was $6.4604, the range of prices were between $6.46 and $6.465. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- The shares subject to the option are fully vested
Billionaire Hedge Funds
